
Candidature YC de Volumetric
Volumetric a été sélectionné par Y Combinator dans le cadre du batch Winter 2020 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.
- Batch YC
- Winter 2020
- Secteur d'activité
- HealthcareIndustrial Bio
- Taille de l'équipe
- 5
- Statut
- Acquired
- Lancé
- 2020
Fondateurs
Jordan MillerCo-Founder and President
Bagrat GrigoryanCo-Founder, COO
Ce que fait Volumetric
About Us Volumetric is a recognized world leader in building living multicellular tissues, with a focus on replicating discrete functions of the human body for basic mechanistic biology, laboratory testing and screening, and drug development. Founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, the full potential of our work is to build whole human organ replacements for patients, made from their own cells. Our Technology and Approach We have invented a suite of breakthrough 3D bioprinting technologies, featured on the cover of Science, that can build human tissue with complex blood vessel networks. We are leveraging this technology in the short term to build patient-specific tissues for drug safety and efficacy testing. Patient cells are taken from a biopsy, added to our proprietary 3D printed tissues, and then drug compounds are injected through the blood vessel network to mimic actual drug delivery in humans. Our vision is that our technology will provide rigorous, reproducible, and predictive outcomes for patients, resulting in drastically improved outcomes for diseases like cancer. More broadly, we see the full potential of our mission as being able to produce functional tissue and organ replacements for diseased or damaged vital organs in the body such as the lung, liver, pancreas, kidney, and heart.
Candidature YC de Volumetric, reconstruite
Candidature Y Combinator
Volumetric, promotion Winter 2020. Les vraies questions de candidature, répondues à partir de données publiques.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Volumetric
Build living multicellular human tissues
We build living human tissues with complex blood vessel networks using proprietary 3D bioprinting technology. Our product replicates discrete human organ functions for biology research, drug testing, and drug safety screening. We take patient cells from biopsies, add them to printed tissues, and deliver drugs through built-in vessels to mimic real human responses. Long term, we aim to replace diseased organs with functional, patient-specific tissues.
We are based in Houston, TX, and the company would remain there after YC.
Houston puts us close to Rice University where our technology started and provides access to biomedical and industrial bio partners. We're rooted here and it's where our team and ecosystem are strongest.
21 réponses supplémentaires dans la candidature complète
se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.
Questions fréquemment posées
Est-ce la vraie candidature YC de Volumetric ?
Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de Volumetric (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme Volumetric se présenterait à YC, pas le texte qu'ils ont soumis.
À quel batch YC Volumetric appartenait-il ?
Volumetric faisait partie du batch Winter 2020 de Y Combinator.
Qui a fondé Volumetric ?
Volumetric a été fondé par Jordan Miller, Bagrat Grigoryan.
Que fait Volumetric ?
Volumetric builds living multicellular tissues with a focus on the…
Comment lire la candidature complète reconstruite ?
Créez un compte Round Funded gratuit. La version complète de la candidature de Volumetric en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.